During the conference call, management directly addressed one of its biggest challenges – high wage growth, driven by pressure from the public healthcare sector – saying that it expects public sector wages to reach the government’s 2022E target in 4Q18E, which would relieve the pressure on MedLife’s costs for the next four years, allowing its margin to expand. Also, while we are unlikely to see significant relief in the coming quarters, looking at the solid revenues growth from the curre...
HEADLINES: * Raiffeisen Int: 1Q18 - strong bottom line, but driven purely by LLPs, as pre-provision profit in line POSITIVE * Romgaz: 1Q18 results affected by poor electricity and storage performance NEGATIVE * CCC: 1Q final numbers weak, matching preliminary statement * AmRest: 1Q EBITDA strong, as expected, miss on bottom line due to taxes and impairments * Rosneft: 1Q18 results - improving FCF is quite encouraging * Play Communications: 1Q18 - 3% miss on adjusted EBITDA ...
HEADLINES: * Isbank: 1Q18 wrap up - a mixed bag, with a beat, one-offs and a major accounting change NEUTRAL * ANY PLC: 1Q18 results review - strong revenue performance mitigated by lower profitability NEUTRAL * Pfleiderer: management recommends PLN 1.2 DPS NEUTRAL * Immofinanz: shareholders vote to appoint a special auditor to investigate sale of Moscow malls NEUTRAL * Cyfrowy Polsat: receives antimonopoly office approval for Netia acquisition NEUTRAL * MedLife: 1Q18E preview...
EME Equity Market – March 2018 Market performance – only Romania and Prague in positive territory. The MSCI EME lost 5.8% mom in March, continuing the negative trend after February’s 1.1% contraction. The Romanian BET index was the best performer in March, +3.1%, while Prague’s PX index remained broadly flat, recording a small gain of 0.3%. On the negative side, the Turkish ISE30 performed poorly, losing 9.1%, followed by the Warsaw WIG20, -7.3%. The Greek ASE index fell by 6.6% and Mosc...
HEADLINES: * Polish utilities: unloved, but (really) cheap again (upgrading to BUY on Enea, Energa & PGE, Tauron stays HOLD) * CE4 macro: inflation - just not taking off. Yet... * PZU: 4Q17 - a solid set of results POSITIVE * OTP Bank: denied approval to take over Banca Romaneasca NEGATIVE * KGHM: 4Q17 financial results - weaker-than-expected EBITDA on higher costs, little FCF NEGATIVE * Bank Pekao: denies press speculation on the decision to merge with Alior * Polish ban...
EME Equity Market – February 2018 Market performance –Moscow the regional top performer in February. In February, the MSCI EME lost 1.1% mom in EUR terms, vs. the 6.6% gain in the previous month. The largest rate of return in February was realised by the MICEX, up 2.1%, followed by Bucharest’s BET (+0.9% mom) and the Turkish ISE30 (+0.7%). The other regional indices ended the month in negative territory, with Warsaw’s WIG20 recording the largest drop (-7.9%) and Budapest’s BUX followin...
HEADLINES: * Romanian coverage universe: growth normalising (TLV, BRD, BVB, FP, SNN, SNP, SNG, COTE, EL, TEL, TGN, M, DIGI, SIF1, SIF2, SIF3, SIF4, SIF5) * Polish banks: parliament reignites works on FX mortgage bill draft NEGATIVE * JSW: 4Q17 trading update - lower-than-expected volumes NEGATIVE * PKN Orlen: settlement of the tender offer for Unipetrol NEUTRAL * Bank of Cyprus: 4Q17E results preview - marginal profitability in 4Q (due out tomorrow) * Kernel: 2Q FY18E preview ...
After a decent correction in 2H17, driven by increased concerns about higher inflation and risk free rates, and against the background of heightened political noise, the Romanian market has had a good start to 2018. The economy seems to be moving back onto a more balanced growth path, with GDP growth estimated at 4.5% and disposable income at 6%. Even though some imbalances remain (the budget deficit likely to exceed 3%) the low starting point for most of the indicators (public debt-to-GDP below...
HEADLINES: * Ford Otosan: 4Q17 review - miss on EBITDA, but ahead on net income NEGATIVE * MedLife: wage growth key factor for FY18E profitability * PGE: preliminary recurring EBITDA in line, net profit misses * Medicalgorithmics: January tests data NEUTRAL * Richter: little clarity on Esmya, but no new negatives during conference call NEGATIVE * BRD-GSG: 4Q17 results conference call takeaways NEUTRAL * EME Strategy: MSCI February QIR - no changes in the EME universe, in l...
HEADLINES: * Turk Telekom: 4Q17 results and FY18E guidance in line, but no cash dividend proposal NEGATIVE * CME: guides for 14-16% OIBDA growth at constant rates in 2018E POSITIVE * Romanian SOEs: government to request 90% dividend payout POSITIVE * Otokar: submits best and final offer for ALTAY NEUTRAL * mBank: takeaways from the post-4Q17 results analyst meeting * Komercni Banka: takeaways from 4Q17 results conference call * Mytilineos: proposal to PPC to upgrade Amyn...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.